Capitol Hill Lawmakers Could Revisit Pearson, DSHEA In 2001
This article was originally published in The Tan Sheet
Executive Summary
Congressional leaders may be looking to the 107th Congress to initiate hearings on FDA's actions in implementing the Pearson v. Shalala decision.
You may also be interested in...
FDA budget
Senate vote on agriculture approps bill expected Oct. 18. Conference report on HR 4461 passed House by a 340-75 vote Oct. 11. Bill provides FDA with $1.22 bil. for fiscal 2001, including salaries, expenses and majority of user fees. CDER receives $317.5 mil., with $6.8 mil. earmarked for adverse event monitoring of drugs. AER funding for dietary supplements/foods is removed in conference report, committee says. CFSAN and its field offices are allocated $285.3 mil., a $30 mil. increase over FY 2000 budget. Food center also is granted $1 mil. to fund a joint University of Mississippi dietary supplement research center
Folic Acid Qualified Health Claims Based On IoM Findings Allowed By CFSAN
Dietary supplements may carry qualified health claims regarding the amount and sources of folic acid effective in reducing the risk of neural tube defects, FDA announces Oct. 10. The Center for Food Safety & Applied Nutrition's decision is in response to one of the four health claims at issue in the Pearson v. Shalala case.
Dietary Supplement, Functional Food Regulatory Harmonization Urged By GAO
Congress should amend the FD&C Act to require that functional foods meet the same regulatory standards that dietary supplements meet, the General Accounting Office recommends in a July 11 report.